Description

Ethyl 1-(6-Quinoxalinyl)-4-Piperidinecarboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic quinoxaline-piperidine hybrid structure. This compound is of significant value in medicinal chemistry research and development, serving as a critical building block for the synthesis of novel bioactive molecules. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly within the fields of oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of potential drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Kinase Inhibitor Development: The quinoxaline moiety makes it a valuable starting material for research into novel kinase inhibitors.
• Chemical Biology Probes: Employed in the design and synthesis of molecular probes for studying biological processes and target validation.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	Ethyl 1-(6-Quinoxalinyl)-4-Piperidinecarboxylate
CAS No.	453557-64-7
Molecular Formula	C16H19N3O2
Molecular Weight	285.34 g/mol
Synonyms	Ethyl 1-(quinoxalin-6-yl)piperidine-4-carboxylate; 4-Piperidinecarboxylic acid, 1-(6-quinoxalinyl)-, ethyl ester; 1-(6-Quinoxalinyl)-4-piperidinecarboxylic Acid Ethyl Ester; Ethyl 1-(6-Quinoxalinyl)isonipecotate; 453557-64-7; Ethyl 1-quinoxalin-6-ylpiperidine-4-carboxylate; 1-Quinoxalin-6-yl-piperidine-4-carboxylic acid ethyl ester
EINECS	Contact for details

Quality Control

Our Ethyl 1-(6-Quinoxalinyl)-4-Piperidinecarboxylate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for advanced pharmaceutical intermediates. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting key parameters such as assay purity and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5% Total impurities ≤ 1.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.